(MedPage Today) — More lawsuits are alleging that patients are not being sufficiently warned of certain severe injuries associated with GLP-1 receptor agonists. (USA Today)
Meanwhile, the U.K.’s Medicines and Healthcare Products Regulatory Agency…
Source link : https://www.medpagetoday.com/endocrinology/generalendocrinology/119713
Author :
Publish date : 2026-02-03 19:59:00
Copyright for syndicated content belongs to the linked Source.
